Similar articles

• Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection.

  Lok AS, Wilson LA, Thomas HC. Lok AS, et al. J Antimicrob Chemother. 1984 Jul;14(1):93-9. doi: 10.1093/jac/14.1.93. J Antimicrob Chemother. 1984. PMID: 6207158 Clinical Trial.
• Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate.

  Hoofnagle JH. Hoofnagle JH. J Hepatol. 1986;3 Suppl 2:S73-80. doi: 10.1016/s0168-8278(86)80103-9. J Hepatol. 1986. PMID: 2439579 Clinical Trial.
• Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.

  Garcia G, Smith CI, Weissberg JI, Eisenberg M, Bissett J, Nair PV, Mastre B, Rosno S, Roskamp D, Waterman K, et al. Garcia G, et al. Ann Intern Med. 1987 Sep;107(3):278-85. doi: 10.7326/0003-4819-107-2-278. Ann Intern Med. 1987. PMID: 2441633 Clinical Trial.
• Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing study.

  Trépo C, Rougier P, Bizollon T, Poupon R, Zarski JP, Quinton A, Miguet JP, Causse X, Chossegros P, Chevallier M. Trépo C, et al. J Hepatol. 1991;13 Suppl 1:S3. doi: 10.1016/0168-8278(91)91711-o. J Hepatol. 1991. PMID: 1720439 Review. No abstract available.
• [Vidarabine phosphate in the treatment of active chronic hepatitis B. A confirmed hope].

  Ouzan D. Ouzan D. Rev Prat. 1992 Jun 1;42(11):1383-6. Rev Prat. 1992. PMID: 1382310 Review. French. No abstract available.